DH — Definitive Healthcare Corp.

Definitive Healthcare (DH) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Total Revenue: $61.5 million, down 1% year-over-year, but above guidance.
• Adjusted EBITDA: $18.1 million, representing a 29% margin, exceeding guidance by $1.1 million.
• Unlevered Free Cash Flow: Approximately $55 million for the trailing 12 months.
• Full Year 2025 Revenue: $241.5 million, a 4% decline year-over-year.
• Adjusted Net Income: $8.6 million, or $0.06 per share for Q4.
• Gross Dollar Retention: Improved by 2 points year-over-year, while net dollar retention declined due to reduced upsell opportunities.

2. Strategic Updates and Business Highlights:

• Operational Progress: Focus on four strategic pillars: data differentiation, integrations, customer success, and innovation.
• Data Differentiation: Successful restoration of claims data volumes and enhancement of core data assets, including mobile phone data for healthcare executives.
• Integrations: Increased automation of integrations, reducing integration time by 25%. Notable new partnerships with platforms like Snowflake and HubSpot.
• Customer Success: Improvement in customer satisfaction and retention rates, with a coordinated effort across sales, support, and success teams.
• Innovation: Strong performance in digital activations, with nearly 30 agencies signed, and a focus on AI integration into products.

3. Forward Guidance and Outlook:

• Q1 2026 Revenue Guidance: Expected between $54 million to $56 million, reflecting a 5% to 9% decline year-over-year.
• Full Year 2026 Revenue Guidance: Projected at $220 million to $226 million, indicating a 6% to 9% decline year-over-year.
• Adjusted EBITDA for 2026: Expected between $53 million to $58 million, with a margin of 24% to 26%.
• NDR Improvement: Anticipated modest improvement in net dollar retention in 2026, with expectations that 2025 marked the bottom.

4. Bad News, Challenges, or Points of Concern:

• Revenue Declines: Continued pressure on revenue with a 4% decline for the full year 2025 and expected declines in 2026.
• Net Dollar Retention: Declined due to reduced upsell opportunities, with ongoing risks tied to customer churn and market dynamics.
• Macroeconomic Environment: Challenges remain in the broader economic landscape, impacting customer budgets and spending.
• Claims Data Disruption: Although remediated, the prior disruption has led to lingering effects on customer satisfaction and retention.

5. Notable Q&A Insights:

• Demand Environment: The demand across end markets remains stable, with some signs of improvement in sales cycles.
• Life Sciences Market: While gross dollar retention improved, net dollar retention faced challenges due to upsell pressures. The company remains cautious about growth in this segment.
• AI Impact: AI is viewed as a competitive advantage, with plans to enhance product offerings and customer engagement through AI integration.
• Renewal Dynamics: The timing of product updates may not have significantly influenced Q4 renewals, but improvements are expected to manifest in early 2026.

Overall, while Definitive Healthcare has made strides in operational improvements and strategic initiatives, it faces ongoing revenue pressures and challenges in net dollar retention. The company remains optimistic about future growth opportunities, particularly with advancements in AI and data integration.